Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity
Year: 2021
Type: article
Source: Cell Host & Microbe
Authors: Rita E. Chen, Brittany K. Smith, John M. Errico, David N. Gordon, Emma S. Winkler, Laura A. VanBlargan, Chandni Desai, Scott A. Handley, Kimberly A. Dowd, Emerito Amaro-Carambot, M. Jane Cardosa, Carlos A. Sariol, Esper G. Kallas, Rafick-Pierre Sékaly, Nikos Vasilakis, Daved H. Fremont, Stephen S. Whitehead, Theodore C. Pierson, Michael S. Diamond
Institutions: Washington University in St. Louis, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Universiti Malaysia Sarawak, University of Puerto Rico, Medical Sciences Campus, University of Puerto Rico System, Universidade de São Paulo, Emory University, The University of Texas Medical Branch at Galveston
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1313233388, The DKE-121 strain as a possible new Dengue virus serotype, G1745307766, G2452401729, A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials, G304139194, G5990125371, G7245223431, National Research Service Award-Medical Scientist, G810873752, G9000064392, Caribbean Primate Research Center Program
OpenAlex ID: W3204069165